What's new at DZP?
In view of the doubts over the correct procedure for agreeing upon medicine programmes, we would like to inform you of a new judgment that was issued by the Voivodship Administrative Court (VAC) in Warsaw (judgment of 14 November 2014, case no. VI Sa/Wa 731/14). The court overturned the Minister of Health's decision to refuse reimbursement for products in medicine programmes on the grounds that contrary to the provisions of the Reimbursement Act it had not agreed upon a medicine programme with the applicant but had merely relied on the national consultant's opinion. This unilateral step taken by the Minister of Health (MH) was deemed by the Court as premature, as in each case the content of a medicine programme should first be set by way of bilateral arrangement between the MH and the applicant.
The case before the MH and the VAC was handled by DZP lawyers, Tomasz Kaczyński, Senior Associate, and Szymon Łajszczak, Associate, in the Life Sciences Practice.
In the appeal, we pointed out to the court that the provisions of the Reimbursement Act differentiate two independent phases of proceedings for product reimbursement in a medicine programme:
The first phase was distinguished by the legislator in article 31(10) and (11) of the Reimbursement Act. According to these provisions, a substantive assessment of the application must be preceded by 60-day agreement upon the content of the medicine programme between the MH and the applicant.
In the proceedings preceding the issue of a decision at first instance, only the stances of external entities were gathered; no agreements were made between the applicant and the MH.
The court upheld the arguments put forward in the appeal that the steps taken by the MH transgressed article 31(10) and (11) of the Reimbursement Act. As the VAC stressed, the MH may not assume beforehand that a negative opinion on a medicine programme originally formed by the national consultant continues to apply where it is possible to make arrangements aimed at a compromise specification of the content of a medicine programme that would enable a product to be classified as reimbursable in accordance with statutory criteria.
As the legislator clearly introduces the concept of agreeing upon the content of a medicine programme, proceedings deprived of bilateral arrangements between the applicant and the MH would have to be deemed unlawful.
Consequently, the court upheld the stance taken by DZP in which, in light of the different stages of the proceedings over reimbursement of products in a medicine programme:
The case in question is already the second case that DZP has won in recent months against the MH. Earlier, in a judgment of 9 September the Supreme Administrative Court (case no. II GSK 998/13) upheld our appeal, overturning the MH's act on the matter of an official interpretation of the provisions of the Reimbursement Act. In its judgment the court ordered the MH to make a substantive assessment of the application for an interpretation of the provisions of the Reimbursement Act filed pursuant to the Act on Freedom of Enterprise. It also pointed out that proceedings to issue an interpretation are regulated by the Code of Administrative Procedure and therefore the Minister cannot refuse to issue an interpretation without running proceedings and ending them with a decision or order.
From 25 May 2018 the General Data Protection Regulation (GDPR) applies in Poland and other European Union countries. We would therefore like to give you several details on the subject of how DZP processes personal data.
The administrator of the personal data is Domański Zakrzewski Palinka Sp.k. (“DZP”; address: Rondo ONZ 1, 00-124 Warszawa). Data are processed for contact purposes and to impart information on changes to provisions and authority practices and on other issues, including events concerning day-to-day legal, economic and cultural issues, inter alia, by sending DZP newsletters. The above is carried out on the basis of legitimate interests, i.e. in accordance with art. 6(1)(f) of the GDPR. Data can also be processed where necessary for the conclusion or performance of a contract and for compliance with a legal obligation to which DZP is subject, i.e. pursuant to art. 6(1)(b) and (c) of the GDPR. Data can be transferred to entities with whose help DZP achieves the indicated aims, including entities maintaining IT infrastructure. Giving data is voluntary and in contractual relations is a requirement for concluding and performing a contract. It is possible to object to data processing, request access to, rectification and erasure of personal data or restriction of processing and data portability. Data are kept until an objection is made, and in contractual relations – throughout the term of the contract and thereafter for a period specified in provisions on archiving and limitations period for claims. Anyone has the right to file a complaint with the President of the Personal Data Protection Office. Questions concerning privacy at DZP can be sent to DZP’s Data Protection Inspector, Macieja Maciejewskiego, at: email@example.com.
New rules on cookies: Domański Zakrzewski Palinka sp.k., as the service provider of the www.dzp.pl website, stores and accesses cookies, i.e. small text information fles sent by a web server and stored on your hard drive, or other data storage medium of a user, for the purposes of: proper functioning of the www.dzp.pl website, confguring the www.dzp.pl website, security and reliability of the www.dzp.pl website, session monitoring, providing advertisements, personalization of the displayed information to the user, or analysis, statistics, research and website trafc auditing.